Background. This analysis consisted of an examination of trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States for a recent 15-year period.
During 1987, cancers of the oral cavity and pharynx were identified as the underlying cause of approximately 8000 deaths in the United States and were listed as a contributing cause in an additional 1700 deaths.' Approximately 30,000 Americans annually have diagnoses of malignant lesions of the oral cavity or pharynx, making it the eighth most common type of cancer (excluding skin cancer), representing approximately 2.5% of all new cancer cases in the United States annually.' Among males, it is the sixth most common cancer site. Relative survival rates of patients with cancers of the oral cavity and pharynx are not reported to have improved in recent years and are lower than for most other major types of cancer. Slightly more than half of patients survive at least 5 years after diagnosi~.~ A recent monograph on cancers of the oral cavity and pharynx provides detailed data on levels and recent trends in mortality and incidence and survival by age and anatomical site.4
In this article, we report on trends in oral and pharyngeal cancer mortality in the United States for the period 1973-1987. We also discuss differences in oral and pharyngeal cancer mortality according to patients' age, sex, race, and state and region of residence. Finally, we examine the roots of mortality variation and decline, to determine whether they arise primarily from changing or differential incidence or from differences in survival among those with oral or pharyngeal malignancies diagnosed.
A large proportion of these cancers are caused by modifiable behaviors. Both and using ~mokeless~-~ tobacco have been strongly implicated as risk factors. Excessive alcohol consumption is strongly suspected of being an etiologic factor, although it is unclear whether alcohol use alone increases the risk of disease, 5.6.10.11 However, there is evidence of a strong interaction between tobacco use and heavy alcohol consumption, whereby the risk of these cancers developing is far greater if both substances are used than if either is used At least two studies have suggested that the use of mouthwash is a risk factor,'3f14 although others have revealed no such relati~nship.'~-'~ Other suggested risk factors include immunodeficiencies, various DNA viruses, Candida infections, and sunlight (lip can-CEZ).'*,'~ There also are a number of suspected occupational risk factors associated with working in the wood, cotton, asphalt, shoe, printing, and forestry industries.20
Mortality associated with oral and pharyngeal cancer could be substantially reduced through improved screening, particularly of individuals at increased risk of having the disease develop."^'* As with other forms of cancer, early detection sharply decreases the probability of dying and provides more treatment option^.^^,'^ The delay between the onset of symptoms and diagnosis tends to be longer for these cancers than for other forms of ~a n c e r .~~-~' Improved screening by dentists and, more importantly, greater awareness of and screening for oral and pharyngeal cancer by physicians could reduce mortality.*'
Materials and Methods
Numerators for mortality rates presented were derived from the National Center for Health Statistics' annual cause of death files for [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] [1987] .' These files contain information on the causes of all deaths reported in the United States during each calendar year. Only the deaths in which oral or pharyngeal cancer (ICD-9-CM codes 140.0-149.9) was designated the underlying cause were included in the analysis. Denominators are based on the United States Bureau of the Census yearly intercensal estimates of population by age, sex, and race for each state.30 Data on incidence and survival are from the Surveillance, Epidemiology, and End Results (SEER) Program sites, which cover approximately 10% of the US p~pulation.~' All rates presented are age-adjusted to the 1970 US population.
Results
During 1987, the age-adjusted underlying mortality associated with oral and pharyngeal cancer for the United States as a whole was 2.9 deaths per 100,000 popula- 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 Although overall mortality associated with oral and pharyngeal cancer decreased considerably during the time period examined, change was not uniform throughout the population. Between 1973 Between -1977 Between and 1983 Between -1987 there was a 16.0% decline among males, whereas the rate for females decreased by only 6.3%. The difference between blacks and whites was even greater with regard to change. While mortality decreased 15.9% for whites, it increased 5.3% for blacks. Mortality decreased 19.4% among white males and 7.6% among white females. It increased 9.8% among black males and 0.9% among black females (Fig. 1) .
Data for the period 1983-1987 show substantial differences in mortality associated with malignancies of the oral cavity and pharynx, according to sex, race, and age ( Table 2 ). For that period, the annualized mortality was 2.7 times higher among men than among women (4.9 versus 1.8 deaths per 100,000). Mortality was almost twice as high among blacks as among whites (5.3 versus 2.9 deaths per 100,000). Among members of other races mortality was lower than for either blacks or whites. Of the race-sex categories the rate was highest by far among black males (9.3 deaths per 100,000) and 1973-1977 to 1983-1987. was lowest among white females (1.7 per 100,000) and females of other races (1.3 per 100,000). The difference between blacks and whites was much greater among males than among females. For the overall U.S. population, oral and pharyngeal cancer mortality for 1983-1987 increased steadily with increasing age, from 0.01 deaths per year per 100,000 population for Americans younger than 15 years of age to 21.7 per 100,000 for those ages 85 years and older (Table 2 ). Mortality increased continuously with age among white males and females, but not among blacks (Fig. 2) . Among black males, mortality decreased steadily for those in age groups older than the 55-64-year group. For black females, mortality stayed relatively constant between the age groups 55-64 years and 75-84 years and increased for those 85 years old and older. Although overall mortality was much higher for blacks than for whites, white men and women in the oldest age groups had higher mortality than did their black counterparts. The age pattern associated with mortality for other races paralleled the pattern for whites but at a somewhat lower level.
Among white men, oral and pharyngeal cancer mortality decreased by at least 17% in every adult age group, except 25-34 years, which experienced a 15.4% increase. However, the mortality at ages 25-34 years was so low that this increase may not be meaningful. Among black men, mortality increased in every adult age group, with the increase exceeding 9% in all but two age groups (Fig. 3) . Mortality among white women declined substantially, except in the oldest age groups. There were small increases for those ages 65-74 years and 75-84 years and a small decrease for those 85 years of age and older. Among black females, mortality de-
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Sd64 6874 7 5 k 85+ Age Figure 3 . Percent change in oral cancer mortality by age and race in the United States for the period 1973-1977 to 1983-1987. creased in every age group younger than 55-64 years but rose substantially for those 55-64 years and all older groups, the ages at which most oral and pharyngeal cancer mortality occurs (Fig. 3) .
Mortality rates during 1983-1987 were highest in the three geographic divisions on the eastern seaboard: the South Atlantic (3.6 deaths per 100,000), New England (3.5 per 100,000), and the Middle Atlantic (3.4 per 100,000) (Fig. 4) . Rates were lowest in the Mountain states (2.3 per 100,000) and the West North Central states (2.5 per 100,000). Mortality declined appreciably from 1973-1977 through 1983-1987 in all nine geographic divisions of the United States, with decreases ranging from 17.7% in the West South Central states and 17.1% in New England to 8.8% in the East South Central states.
Among individual states, the mortality was highest by far in the District of Columbia (7.7 deaths per 100,000), followed by South Carolina (4.1 per 100,000), and Rhode Island (4.0 per 100,000) (Fig. 5 ). The lowest rates were found in Utah (1.6 per 100,000), South Dakota (1.8 per 100,000), and Wyoming (1.9 per 100,000). Despite that the District of Columbia had the highest mortality, it experienced the greatest improvement, a decline of 36. 4% from 1973-1977 through 1983-1987. The next largest declines were recorded in Nebraska (31.6%) and Delaware (23.9%). Mortality associated with oral and pharyngeal malignancies increased in nine states, led by Alaska (24.0%) and South Carolina (17.7%).
Discussion
These results raise at least two questions that warrant discussion and closer examination. First, why are mortality patterns associated with oral and pharyngeal cancer so different between the sexes and among races? Second, what accounts for the steady decline in mortality: falling disease incidence, improved survival rates, or a combination of the two?
Differences in Mortality by Sex and Race
The available data on incidence of and mortality associated with oral and pharyngeal cancer suggest that gender and racial differences in mortality have different causes. Most of the disparity between men and women arises from differences in disease incidence, presumably stemming largely from behavioral and risk factor differences between the sexes, such as greater use of tobacco and alcohol among men. Among whites, the male/female ratio for mortality from these cancers for 1983-1987 was 2.6, the same as the ratio for incidence. In addition, 5-year survival rates for 1981-1986 were similar, 52.0% formales and 56.3% for females. Among blacks, the male/female ratios also were similar: 4.2 for mortality and 3.5 for incidence. Thus, the major difference between men and women appears to lie in whether or not they have oral or pharyngeal cancer develop. Differences in survival are relatively small, except among blacks, for whom the 5-year survival rates were 42.5% for females and 26.8% for males. With the recent narrowing of the gap between males and females in the prevalence of cigarette smoking, we might anticipate a reduction in the disparity between men and women in mortality associated with malignancies of the oral cavity and pharynx.
However, the difference in oral and pharyngeal cancer mortality patterns between blacks and whites derives more from differences in survival rates than from differences in disease incidence. The 5-year survival rate for men with cancer diagnosed between 1981 and 1986 was 52.0% among whites, but only 26.8% among blacks. For women, survival rates were 56.3% among whites and 42.5% among blacks. However, the black/white incidence ratio was only 1.5 for males and 1.1 for females. Among people ages 65 and older, the reported incidence was higher among whites than blacks. These ratios suggest that, although there clearly Figure 4 . Oral cancer mortality age-adjusted rates per 100,000 by US geographic divisions for the period 1983-1987. are racial differences in the likelihood of oral or pharyngeal cancer developing, differences in mortality between the races can be attributed primarily to disparities in survival probabilities.
An examination of SEER data suggests that these disparities are attributable to two factors, First, the disease tends to be diagnosed at a more advanced stage in blacks than in whites. Second, regardless of the stage at which diagnosis is made, blacks typically have shorter survival times after oral or pharyngeal cancer has been discovered. At the time of cancer diagnoses made between 1974 and 1986, lesions were twice as likely to be localized in white males as in black males (4 1 YO versus 21%) ( Table 3) . Among females, the proportion of localized lesions was 40% for whites and 27% for blacks.
Likewise, oral and pharyngeal cancers were more likely to have been diagnosed in a regional or distant stage by the time of diagnosis in blacks than in whites. These figures demonstrate the need for a greater emphasis on oral and pharyngeal cancer detection activities among blacks.
As with most cancers, the stage at diagnosis of oral and pharyngeal cancer is highly correlated with the likelihood of s~r v i v a l . '~,~~ For cancers diagnosed between 1974 and 1986, the 5-year survival rate of patients was 75% if the cancer was localized when first diagnosed, 41% if it was regionalized, and 18% if it had reached a distant site3 (Table 4) . However, even when the stage at diagnosis is held constant, survival is much greater among white men then among black men. For women, survival differences between blacks and whites are relatively small for localized and regionalized cancers and cancers diagnosed with distant metastases and nonexistent for distant site cancers.
Another noteworthy difference between blacks and whites is the age pattern associated with death from oral and pharyngeal cancer. For blacks, and particularly black men, mortality increases to its maximum at approximately age 60 years and levels. Mortality for whites continues increasing to the oldest age group. A possible explanation for these differing patterns is that members of the oldest black cohorts have had a lower risk of cancer developing than' have slightly younger blacks. In such instances, cross-sectional age-specific rates would give the impression that mortality was not increasing monotonically with age. This hypothesis is supported by the age pattern associated with black mortality associated with oral and pharyngeal cancer being paralleled by the age pattern associated with inciden~e.~ Devesa et al.31 compared mortality for birth cohorts and found that mortality among nonwhite men has increased considerably more rapidly for those younger than 60 years than for older groups. If the mortality pattern by age among blacks is a result of increased risk in younger cohorts, we would expect to see the pattern among blacks gradually come to resemble that of whites. Figure 5 . Oral cancer mortality age-adjusted rates per 100,000 by state for the period 1983-1987.
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Components of Mortality Decline
Unfortunately, the data used in this analysis do not provide a conclusive answer to the question of what has contributed most to the mortality decline, but they do lend some insight. A closer examination of changes in oral and pharyngeal cancer mortality reveals an apparent inconsistency between the recent downward movement in mortality and trends in incidence and survival rates. A substantial decrease in cancer mortality should be preceded by a decrease in &ease incidence or an Tables IV-13 to IV-21. increase in probabilities of survival. However, despite that mortality associated with oral and pharyngeal malignancies reportedly decreased by 19% nationwide and 16% in SEER Program sites between 1973 and 1987, no improvement in incidence or survival was noted for these sites. This was the only major type of cancer for which a substantial decline in mortality was not accompanied by corresponding improvements in incidence or s~r v i v a l .~ The reported incidence of oral and pharyngeal cancer for SEER Program sites remained virtually unchanged, at 11.3 cases per 100,000 population per year during both 1973-1977 and 1983-1987 . Likewise, recent data reveal no improvement in survival rates for individuals with these cancers diagnosed. The proportions surviving for at least 5 years actually decreased from 52.9% for diagnoses made from 1974 to 1976 to 50.9% for diagnoses made from 1981 to 1986. Even if survival for periods shorter than 5 years is examined, there is no indication of improvement. For instance, the 3-year survival rate fell from 62.2% for diagnoses made in 1974-1976 to 61.2% for diagnoses made during 1984-1986. The 1-year survival rate decreased from 80.2% to 79.6%. Table 5 reveals that in all race-gender categories, mortality declined substantially more (or in the case of black males and females increased substantially less) than expected, given the reported changes in incidence and survival. The inconsistency persists even within age groups for each race-gender category.
It seems safe to assume that oral and pharyngeal cancer mortality did decrease substantially during the period in question. There is no reason to believe that these cancers were overreported as a cause of death in earlier years or that physicians increasingly failed to note their presence as a cause of death in more recent years. The reported decline in mortality has been steady and pervasive and is reflected in national and SEER data. Thus, it seems that incidence or survival must have improved, despite the failure of SEER statistics to reflect such improvement.
It is conceivable that a decline in incidence has been masked by improved or earlier detection of oral and pharyngeal cancer in recent years. Although there has been no decrease in oral and pharyngeal cancer incidence at SEER centers, a Connecticut study revealed a substantial decline in the incidence of these cancers among males since the early 1 9 7 0~.~* Unfortunately, we cannot say with certainty that improved detection is responsible for the observed inconsistency. One generally would expect to note improvements in survival as a result of improved early detection. However, as mentioned, there was no increase in observed survival rates.
Knowing the extent to which mortality change is tied to changes in incidence or in survival rates is important in that it is an indicator of the degree to which mortality is being affected by behavioral and exposure changes (incidence) as opposed to detection and treatment changes (survival). White males are the only sexrace group to have registered a decline in incidence, and this group also has the greatest decline in smoking in recent years. If incidence has fallen but survival has not, it could be concluded that recent changes have occurred primarily because of a reduction in behaviors and exposures that can cause oral and pharyngeal cancer and not because cancers are being detected earlier and treated more effectively.
